Wall Street RegretsThe regret calculator.

What if you'd held NVS?

A $1,000 investment in Novartis AG (NVS) at the month-end close of 1996-11 would be worth $13,989 at the close of 2026-08 — +1298.9% total return, dividends reinvested. The same $1,000 in the S&P 500 would be worth $10,182.

$1,000 since 1996$13,989Total return+1298.9%Multiple14.0×CAGR+9.3%

Your scenario

Dates resolve to the nearest month-end close.
Leave empty for "held until today".
Invested at each month-end. Starts on the buy date.

Result

Worth$13,989Gain+$12,989 (+1298.9%)Multiple14.0×CAGR+9.3%

    If you'd bought $1,000 at the start of each year

    Value of $1,000 invested on January 1 of each year, held to 2026-08, dividends included.

    2000$11,1482001$8,8772002$10,7372003$10,5332004$8,2722005$7,3742006$7,1032007$6,3842008$6,6192009$7,0132010$6,1372011$5,4642012$5,4032013$4,6712014$3,5442015$2,9742016$3,1142017$3,5402018$2,9642019$2,7982020$2,2012021$2,1292022$2,2102023$2,0452024$1,7612025$1,7612026$1,198

    Every year, $1,000 from 1996

    YearValue of $1,000Year return
    1996$1,000
    1997$1,415+41.5%
    1998$1,704+20.4%
    1999$1,274-25.3%
    2000$1,600+25.6%
    2001$1,322-17.3%
    2002$1,348+1.9%
    2003$1,717+27.3%
    2004$1,926+12.2%
    2005$1,999+3.8%
    2006$2,224+11.3%
    2007$2,145-3.5%
    2008$2,025-5.6%
    2009$2,314+14.3%
    2010$2,599+12.3%
    2011$2,628+1.1%
    2012$3,040+15.7%
    2013$4,007+31.8%
    2014$4,775+19.2%
    2015$4,560-4.5%
    2016$4,011-12.0%
    2017$4,791+19.5%
    2018$5,075+5.9%
    2019$6,453+27.1%
    2020$6,669+3.3%
    2021$6,425-3.7%
    2022$6,942+8.1%
    2023$8,063+16.1%
    2024$8,065+0.0%
    2025$11,851+47.0%
    2026$14,199+19.8%

    Best and worst month-end to buy

    The best single month-end close to have bought NVS was 1996-12 ($11.29): $1,000 then is $14,199 today. The worst was 2026-02 ($164): $1,000 then is $980.

    FAQ

    What would $1,000 in NVS be worth today?

    A $1,000 investment in Novartis AG (NVS) at the start of 1996 would be worth about $13,989 today, a total return of +1298.9%. Dividends are reinvested in these figures.

    What were the best and worst years for NVS?

    Novartis AG (NVS)'s strongest calendar year since 1996 was 2025, a +47.0% return — $1,000 held through that year became about $1,470 by year-end. Its weakest year was 1999, at -25.3%.

    Does the calculator include dividends and splits?

    Yes where available. Prices are adjusted for both stock splits and reinvested dividends (total return), the same measure brokerages use.

    How much would $100 per month in NVS have grown?

    Investing $100 at the end of every month since 1996-11 would have grown to about $202,483 on $35,800 invested.

    Did NVS beat the S&P 500?

    Over the same period, $1,000 in the S&P 500 index would be worth $10,182. NVS beat the S&P 500 by +37.4% in total return.

    Is this investment advice?

    No. Wall Street Regrets is an entertainment and education tool. Every number is a historical calculation, not a prediction, and past performance never guarantees future results.

    Methodology

    Novartis AG (NVS) historical total-return data from 1996-11 to 2026-08, reduced to month-end closes for the tables above.

    Returns use adjusted close prices from Yahoo Finance historical data — adjusted for stock splits and reinvested dividends — the same convention used by major brokerages. A "year" scenario invests $1,000 at the prior December's month-end close and values it at the latest available month-end close. Non-USD amounts are converted at historical month-end exchange rates (Yahoo Finance): to USD on the buy date and back to your currency at the latest rate, so the return reflects the currency move as well as the asset.

    Month-end resolution means intra-month extremes are not captured in tables; the calculator uses exact trading-day closes where daily data is available. Figures ignore taxes, fees, and the currency effects of non-USD listings. History is not a forecast. Wall Street Regrets is entertainment, not investment advice.

    Full methodology →

    What if you'd held…

    Data: adjusted close prices via Yahoo Finance. As of 2026-08. Not financial advice.